Neuramis Deep

Neuramis utilizes patented SHAPE™ cross-linking technology (US Patent 9,987,456) to create monophasic HA gel with 20mg/ml concentration. The optimized 3D matrix structure achieves 98.7% cross-linking efficiency and BDDE residue <0.4ppm. Particle size distribution of 300-500μm ensures natural tissue integration while maintaining 92.4% viscosity retention at 6 months post-injection.

Product Specifications

• Active Ingredients: Hyaluronic Acid 20mg/ml, Lidocaine 0.3%
• Cross-linker: BDDE ≤0.4ppm
• : 27G×13mm sterile
• Volume: 1.0ml/
• Storage: 2-25°C protected from light
• Shelf Life: 24 months
• Indications: Moderate-severe facial wrinkles (Glogau II-III)
• Injection Depth: Mid-to-deep dermis
• Technique: Linear threading or serial puncture
• Max Dose: 2.0ml per session
• Anesthesia: Not required (pre-incorporated)